Idexx Laboratories
IDXX
971 hedge funds and large institutions have $37.5B invested in Idexx Laboratories in 2020 Q4 according to their latest regulatory filings, with 180 funds opening new positions, 317 increasing their positions, 324 reducing their positions, and 48 closing their positions.
275% more first-time investments, than exits
New positions opened: 180 | Existing positions closed: 48
38% more funds holding in top 10
Funds holding in top 10: 24 → 33 (+9)
30% more capital invested
Capital invested by funds: $28.8B → $37.5B (+$8.6B)
15% more funds holding
Funds holding: 846 → 971 (+125)
0.25% more ownership
Funds ownership: 86.37% → 86.61% (+0.25%)
2% less repeat investments, than reductions
Existing positions increased: 317 | Existing positions reduced: 324
40% less call options, than puts
Call options by funds: $63.7M | Put options by funds: $107M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$120M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$102M |
| 3 |
Morgan Stanley
New York
|
+$69.7M |
| 4 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
+$69.2M |
| 5 |
MNG
Manning & Napier Group
Fairport,
New York
|
+$69M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCP
Durable Capital Partners
Bethesda,
Maryland
|
-$81.9M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$67.5M |
| 3 |
Neuberger Berman Group
New York
|
-$63.8M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$63.7M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$63.7M |
IDXX Hedge Fund Activity: Q4 2020 in Review
971 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q4 2020, worth a combined $37.5B — up 30% from $28.8B a quarter earlier.
Buyers outnumbered sellers: 180 funds opened new IDXX positions and 48 closed out — a net gain of 132 holders — while 317 added to existing stakes and 324 trimmed.
The largest buyer was Carillon Tower Advisers, adding an estimated $120M. The largest seller was Durable Capital Partners, cutting an estimated $81.9M.
- 971 institutional investors held Idexx Laboratories (IDXX) as of Q4 2020, up from 846 in Q3 2020.
- Funds reported $37.5B of Idexx Laboratories stock for Q4 2020, up 30% quarter-over-quarter.
- 180 funds opened new Idexx Laboratories positions in Q4 2020 and 48 closed out, a net change of +132 holders.
- The largest Idexx Laboratories buyer in Q4 2020 was Carillon Tower Advisers, an estimated $120M added.
- The largest Idexx Laboratories seller in Q4 2020 was Durable Capital Partners, an estimated $81.9M sold.
Based on aggregated 13F filings for Q4 2020.